Injectable atypical antipsychotics for agitation in borderline personality disorder: A case report

J. C. Pascual; M. Madre; J. Soler; J. Barrachina; M. J. Campins; E. Alvarez; Victor Perez

doi:10.1055/s-2006-941489

Injectable atypical antipsychotics for agitation in borderline personality disorder: A case report

J. C. Pascual, M. Madre, J. Soler, J. Barrachina, M. J. Campins, E. Alvarez, Victor Perez

Producció científica: Contribució a una revista › Article › Recerca › Avaluat per experts

27 Cites (Scopus)

Resum

Agitation is relatively common among Borderline Personality Disorder (BPD) patients in Psychiatric Emergency Services (PES). New injectable atypical antipsychotics are indicated for treatment in agitated psychotic or maniac patients but not for agitated BDP patients. Twenty agitated BPD patients were treated with intramuscular atypical antipsychotics (olanzapine or ziprasidone). Results suggest intramuscular atypical antipsychotics may be effective, fast and safe for treating acute BPD patients. © Georg Thieme Verlag KG Stuttgart.

Idioma original	English
Pàgines (de-a)	117-118
Revista	Pharmacopsychiatry
Volum	39
Número	3
DOIs	https://doi.org/10.1055/s-2006-941489
Estat de la publicació	Publicada - 1 de maig 2006

Accés al document

10.1055/s-2006-941489

Com citar-ho

@article{57a4ad2d1a29494eacd26eeaebad5f8f,

title = "Injectable atypical antipsychotics for agitation in borderline personality disorder: A case report",

abstract = "Agitation is relatively common among Borderline Personality Disorder (BPD) patients in Psychiatric Emergency Services (PES). New injectable atypical antipsychotics are indicated for treatment in agitated psychotic or maniac patients but not for agitated BDP patients. Twenty agitated BPD patients were treated with intramuscular atypical antipsychotics (olanzapine or ziprasidone). Results suggest intramuscular atypical antipsychotics may be effective, fast and safe for treating acute BPD patients. {\textcopyright} Georg Thieme Verlag KG Stuttgart.",

author = "Pascual, {J. C.} and M. Madre and J. Soler and J. Barrachina and Campins, {M. J.} and E. Alvarez and Victor Perez",

year = "2006",

month = may,

day = "1",

doi = "10.1055/s-2006-941489",

language = "English",

volume = "39",

pages = "117--118",

journal = "Pharmacopsychiatry",

issn = "0176-3679",

publisher = "Georg Thieme Verlag",

number = "3",

}

TY - JOUR

T1 - Injectable atypical antipsychotics for agitation in borderline personality disorder: A case report

AU - Pascual, J. C.

AU - Madre, M.

AU - Soler, J.

AU - Barrachina, J.

AU - Campins, M. J.

AU - Alvarez, E.

AU - Perez, Victor

PY - 2006/5/1

Y1 - 2006/5/1

N2 - Agitation is relatively common among Borderline Personality Disorder (BPD) patients in Psychiatric Emergency Services (PES). New injectable atypical antipsychotics are indicated for treatment in agitated psychotic or maniac patients but not for agitated BDP patients. Twenty agitated BPD patients were treated with intramuscular atypical antipsychotics (olanzapine or ziprasidone). Results suggest intramuscular atypical antipsychotics may be effective, fast and safe for treating acute BPD patients. © Georg Thieme Verlag KG Stuttgart.

AB - Agitation is relatively common among Borderline Personality Disorder (BPD) patients in Psychiatric Emergency Services (PES). New injectable atypical antipsychotics are indicated for treatment in agitated psychotic or maniac patients but not for agitated BDP patients. Twenty agitated BPD patients were treated with intramuscular atypical antipsychotics (olanzapine or ziprasidone). Results suggest intramuscular atypical antipsychotics may be effective, fast and safe for treating acute BPD patients. © Georg Thieme Verlag KG Stuttgart.

U2 - 10.1055/s-2006-941489

DO - 10.1055/s-2006-941489

M3 - Article

SN - 0176-3679

VL - 39

SP - 117

EP - 118

JO - Pharmacopsychiatry

JF - Pharmacopsychiatry

IS - 3

ER -

Injectable atypical antipsychotics for agitation in borderline personality disorder: A case report

Resum

Accés al document

Fingerprint

Com citar-ho